Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    November 2018
  1. ROVIN BH, Solomons N, Pendergraft WF 3rd, Dooley MA, et al
    A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
    Kidney Int. 2018 Nov 5. pii: S0085-2538(18)30628.
    PubMed     Text format     Abstract available


  2. BECK LH JR, Salant DJ
    Deep pockets are not necessarily a good thing in membranous nephropathy: evidence for a modifier allele.
    Kidney Int. 2018;94:855-857.
    PubMed     Text format     Abstract available


    October 2018
  3. MULLER MB, Hoppe JM, Bideak A, Lux M, et al
    Exclusive expression of transmembrane TNF aggravates acute glomerulonephritis despite reduced leukocyte infiltration and inflammation.
    Kidney Int. 2018 Oct 30. pii: S0085-2538(18)30594.
    PubMed     Text format     Abstract available


  4. BRIX SR, Noriega M, Tennstedt P, Vettorazzi E, et al
    Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30552.
    PubMed     Text format     Abstract available


  5. RAMACHANDRAN R, Yadav AK, Sethi J, Gupta KL, et al
    Antibodies to M-type phospholipase receptor and immunological remission in treatment-resistant and relapsing membranous nephropathy.
    Kidney Int. 2018;94:829-830.
    PubMed     Text format    


  6. NACHMAN PH
    Repeat kidney biopsy for lupus nephritis: an important step forward.
    Kidney Int. 2018;94:659-661.
    PubMed     Text format     Abstract available


    August 2018
  7. WANG HY, Cui Z, Xie LJ, Zhang LJ, et al
    HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy.
    Kidney Int. 2018 Aug 26. pii: S0085-2538(18)30441.
    PubMed     Text format     Abstract available


    July 2018
  8. DE ROSA M, Azzato F, Toblli JE, De Rosa G, et al
    A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30395.
    PubMed     Text format     Abstract available


  9. FLOEGE J, Daha MR
    IgA nephropathy: new insights into the role of complement.
    Kidney Int. 2018;94:16-18.
    PubMed     Text format     Abstract available


    June 2018
  10. ARKATKAR T, Jacobs HM, Du SW, Li QZ, et al
    TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Kidney Int. 2018 Jun 12. pii: S0085-2538(18)30252.
    PubMed     Text format     Abstract available


    May 2018
  11. SAHA MK, Julian BA, Novak J, Rizk DV, et al
    Secondary IgA nephropathy.
    Kidney Int. 2018 May 24. pii: S0085-2538(18)30245.
    PubMed     Text format     Abstract available


  12. ZHU L, Guo WY, Shi SF, Liu LJ, et al
    Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30214.
    PubMed     Text format     Abstract available


  13. GUMBER R, Cohen JB, Palmer MB, Kobrin SM, et al
    A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30211.
    PubMed     Text format     Abstract available


  14. LIM CC, Choo JCJ, Chan CM, Woo KT, et al
    Age-adjusted global glomerulosclerosis in addition to Oxford histological classification of IgA nephropathy.
    Kidney Int. 2018;93:1250.
    PubMed     Text format    


    April 2018
  15. SAID SM, Cosio FG, Valeri AM, Leung N, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30175.
    PubMed     Text format     Abstract available


  16. ELLER K, Rosenkranz AR
    Atypical chemokine receptors-"chemokine PACMANs" as new therapeutic targets in glomerulonephritis.
    Kidney Int. 2018;93:774-775.
    PubMed     Text format     Abstract available



  17. Fu J, Wang Z, Lee K, et al. Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis. Kidney Int. 2018;93:416-429.
    Kidney Int. 2018;93:1018.
    PubMed     Text format    


  18. VAN DE LOGT AE, Dahan K, Rousseau A, van der Molen R, et al
    Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
    Kidney Int. 2018;93:1016-1017.
    PubMed     Text format    


    March 2018
  19. FLOEGE J
    IgA nephropathy: toward more specific diagnosis (and rescue of snails).
    Kidney Int. 2018;93:542-544.
    PubMed     Text format     Abstract available


    February 2018
  20. BAJEMA IM, Wilhelmus S, Alpers CE, Bruijn JA, et al
    Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.
    Kidney Int. 2018 Feb 16. pii: S0085-2538(17)30859.
    PubMed     Text format     Abstract available


  21. MOON JS, Mun CH, Kim JH, Cho JY, et al
    Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
    Kidney Int. 2018 Feb 3. pii: S0085-2538(17)30853.
    PubMed     Text format     Abstract available


    January 2018
  22. BIDEAK A, Blaut A, Hoppe JM, Muller MB, et al
    The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis.
    Kidney Int. 2018 Jan 22. pii: S0085-2538(17)30829.
    PubMed     Text format     Abstract available


  23. SUZUKI H, Yasutake J, Makita Y, Tanbo Y, et al
    IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30799.
    PubMed     Text format     Abstract available


  24. BOMBACK AS, Santoriello D, Avasare RS, Regunathan-Shenk R, et al
    C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Kidney Int. 2018 Jan 6. pii: S0085-2538(17)30802.
    PubMed     Text format     Abstract available


  25. STOKES MB, D'Agati VD
    Full-house glomerular deposits: beware the sheep in wolf's clothing.
    Kidney Int. 2018;93:18-20.
    PubMed     Text format     Abstract available


    December 2017
  26. EYMAEL J, Sharma S, Loeven MA, Wetzels JF, et al
    CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis.
    Kidney Int. 2017 Dec 21. pii: S0085-2538(17)30770.
    PubMed     Text format     Abstract available


  27. DICK J, Gan PY, Ford SL, Odobasic D, et al
    C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
    Kidney Int. 2017 Dec 11. pii: S0085-2538(17)30768.
    PubMed     Text format     Abstract available


    November 2017
  28. AMANN K
    Do ANCAs make the difference in lupus nephritis?
    Kidney Int. 2017;92:1048-1050.
    PubMed     Text format     Abstract available


  29. FU J, Wang Z, Lee K, Wei C, et al
    Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis.
    Kidney Int. 2017 Nov 1. pii: S0085-2538(17)30671.
    PubMed     Text format     Abstract available


    October 2017
  30. THURMAN JM, Laskowski J
    Complement factor H-related proteins in IgA nephropathy-sometimes a gentle nudge does the trick.
    Kidney Int. 2017;92:790-793.
    PubMed     Text format     Abstract available


    September 2017
  31. SINGH G, Bhardwaj S, Singh L, Sinha A, et al
    Proliferative glomerulonephritis with monotypic IgA-kappa deposits in a 10-year-old.
    Kidney Int. 2017;92:765-766.
    PubMed     Text format    


    August 2017
  32. DE FIJTER JW
    Recurrence of glomerulonephritis: an underestimated and unmet medical need.
    Kidney Int. 2017;92:294-296.
    PubMed     Text format     Abstract available


  33. FLOEGE J
    Mucosal corticosteroid therapy of IgA nephropathy.
    Kidney Int. 2017;92:278-280.
    PubMed     Text format     Abstract available


    July 2017
  34. DAI Y, Chen A, Liu R, Gu L, et al
    Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor alpha.
    Kidney Int. 2017 Jul 27. pii: S0085-2538(17)30321.
    PubMed     Text format     Abstract available


  35. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Text format     Abstract available


  36. TURNER-STOKES T, Wilson HR, Morreale M, Nunes A, et al
    Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30324.
    PubMed     Text format     Abstract available


  37. GALSGAARD J, Persson F, Hansen TW, Jorsal A, et al
    Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Kidney Int. 2017 Jul 13. pii: S0085-2538(17)30310.
    PubMed     Text format     Abstract available


  38. BOJIC M, Kozakowski N, Becede M, Kerschbaumer A, et al
    The Case | Myeloid bodies in the kidney biopsy of a patient with systemic lupus erythematosus.
    Kidney Int. 2017;92:271-272.
    PubMed     Text format    


    June 2017
  39. MEDJERAL-THOMAS NR, Lomax-Browne HJ, Beckwith H, Willicombe M, et al
    Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
    Kidney Int. 2017 Jun 30. pii: S0085-2538(17)30256.
    PubMed     Text format     Abstract available


  40. TORTAJADA A, Gutierrez E, Goicoechea de Jorge E, Anter J, et al
    Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
    Kidney Int. 2017 Jun 18. pii: S0085-2538(17)30254.
    PubMed     Text format     Abstract available


  41. ALLEN PJ, Chadban SJ, Craig JC, Lim WH, et al
    Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
    Kidney Int. 2017 Jun 7. pii: S0085-2538(17)30208.
    PubMed     Text format     Abstract available


  42. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    PubMed     Text format     Abstract available


    May 2017
  43. GUL A, Harford A, Zager P
    Mendelian randomization to establish the causality of uric acid with diabetic nephropathy in type 1 diabetics.
    Kidney Int. 2017;91:1005-1007.
    PubMed     Text format     Abstract available


    April 2017
  44. YAMANOUCHI M, Skupien J, Niewczas MA, Smiles AM, et al
    Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30112.
    PubMed     Text format     Abstract available


    March 2017
  45. KROLEWSKI AS, Skupien J, Rossing P, Warram JH, et al
    Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30081.
    PubMed     Text format     Abstract available


  46. TRIMARCHI H, Barratt J, Cattran DC, Cook HT, et al
    Oxford Classification of IgA nephropathy 2016-the role of crescentic lesions: an update from the IgA Nephropathy Classification Working Group.
    Kidney Int. 2017 Mar 21. pii: S0085-2538(17)30101.
    PubMed     Text format     Abstract available


  47. ROSENZWAJG M, Languille E, Debiec H, Hygino J, et al
    B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30039.
    PubMed     Text format     Abstract available


  48. VIGNON M, Cohen C, Faguer S, Noel LH, et al
    The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
    Kidney Int. 2017;91:720-728.
    PubMed     Text format     Abstract available


  49. HE X, Cheng R, Park K, Benyajati S, et al
    Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway.
    Kidney Int. 2017;91:642-657.
    PubMed     Text format     Abstract available


    February 2017
  50. AHOLA AJ, Sandholm N, Forsblom C, Harjutsalo V, et al
    The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes.
    Kidney Int. 2017 Feb 21. pii: S0085-2538(16)30757.
    PubMed     Text format     Abstract available


    January 2017
  51. KLEMIS V, Ghura H, Federico G, Wurfel C, et al
    Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
    Kidney Int. 2017 Jan 31. pii: S0085-2538(16)30706.
    PubMed     Text format     Abstract available


    December 2016
  52. KIM CS, Bae EH, Ma SK, Kim SW, et al
    The Case | Seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient.
    Kidney Int. 2016;90:1389-1390.
    PubMed     Text format    


    November 2016
  53. YOU H, Gao T, Raup-Konsavage WM, Cooper TK, et al
    Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30598.
    PubMed     Text format     Abstract available


    July 2016
  54. TAKASHIMA S, Fujita H, Fujishima H, Shimizu T, et al
    Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
    Kidney Int. 2016 Jul 27. pii: S0085-2538(16)30273.
    PubMed     Text format     Abstract available


    April 2016
  55. KLESSENS CQ, Woutman TD, Veraar KA, Zandbergen M, et al
    An autopsy study suggests that diabetic nephropathy is underdiagnosed.
    Kidney Int. 2016 Apr 9. pii: S0085-2538(16)00313.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: